Dr. Robert Omwoyo Omuria, MD

Dr. Omuria practices at Bon Secours St. Francis Medical Center in Midlothian, Virginia, part of Bon Secours Mercy Health.

Dr. Omuria's NPI, 1962696856, was assigned on September 4, 2007. Dr. Omuria holds Virginia license 0101251839.

Dr. Omuria's primary practice is Bon Secours St. Francis Medical Center, at 13710 St Francis Boulevard, Midlothian, VA 23114 in Chesterfield County. The practice phone is (804) 594-7400.

Dr. Omuria's primary practice is Bon Secours St. Francis Medical Center in Midlothian, Virginia, part of Bon Secours Mercy Health. The medical group on file is Vituity. Dmand AI also links Dr. Omuria to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Omuria practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Omuria's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Omuria's licenses on file in 2 states: Virginia and Arizona.

CMS data shows 982 Medicare services from Dr. Omuria across 5 procedure codes in 2024, for 437 Medicare patients. Medicare paid $96,793 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 437 Medicare patients who saw Dr. Omuria in 2024. The largest group is 75 to 84, with 162 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Omuria's median patient age at 71, with 56% women.

In 2024, Dr. Omuria wrote 337 Medicare Part D claims for 155 patients. 88% of them were for generic drugs. CMS names the drug for 129 of them, across 8 drugs with 11 or more claims each, at $9,958 in total drug cost. In 2023, CMS named 189 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Omuria for performance year 2024, reported as part of a group. Dr. Omuria accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Omuria from 3 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $177.